Related Experiment Video
Updated: Oct 26, 2025

Author Spotlight: Ultrasound-Guided Needle Release Combined with Corticosteroid Injection for the Treatment of Supinator Syndrome
Published on: May 26, 2023
Musculoskeletal steroid injections during the COVID-19 pandemic
Mark Bugeja1, Jasmine Mariani1, Jessica Dowling1
1Department of Trauma, Orthopaedics and Sports Medicine, Mater Dei Hospital, Triq Dun Karm, Msida, MSD2090, Malta.
Introduction:
This study aims to determine whether musculoskeletal corticosteroid injections increase the risk for COVID-19.
Method:
734 patients who received a corticosteroid injection during the COVID-19 pandemic were followed and their COVID status within 30 days after the injection checked. The results were then compared with an age and sex matched control group.
Results:
No statistically significant difference in the frequency of COVID-19 cases between the two groups was found.
Conclusion:
It appears that the use of musculoskeletal corticosteroid injections during the COVID-19 pandemic does not confer increased risk of contracting the virus.
Related Concept Videos
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
The binding of dantrolene to the RYR1...
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
Skeletal Muscle Relaxants: Adverse Effects
Unlike...
Myocarditis III: Medical Management
Skeletal Muscle Relaxants: Therapeutic Uses
Drug Accumulation During Multiple Dosing: Repetitive IV Injections

